These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 31942669)

  • 1. A randomised controlled study of high intensity exercise as a dishabituating stimulus to improve hypoglycaemia awareness in people with type 1 diabetes: a proof-of-concept study.
    Farrell CM; McNeilly AD; Fournier P; Jones T; Hapca SM; West D; McCrimmon RJ
    Diabetologia; 2020 Apr; 63(4):853-863. PubMed ID: 31942669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High intensity interval training as a novel treatment for impaired awareness of hypoglycaemia in people with type 1 diabetes (HIT4HYPOS): a randomised parallel-group study.
    Farrell CM; McNeilly AD; Hapca S; Fournier PA; Jones TW; Facchinetti A; Cappon G; West DJ; McCrimmon RJ
    Diabetologia; 2024 Feb; 67(2):392-402. PubMed ID: 38010533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-intensity training as a novel treatment for impaired awareness of hypoglycaemia in type 1 diabetes [HIT4HYPOS]: Protocol for a randomized parallel-group study.
    Farrell CM; McNeilly AD; West D; McCrimmon RJ
    Endocrinol Diabetes Metab; 2021 Jan; 4(1):e00166. PubMed ID: 33532608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of self-awareness of hypoglycemia in adults with long-standing type 1 diabetes: hyperinsulinemic-hypoglycemic clamp substudy results from the HypoCOMPaSS trial.
    Leelarathna L; Little SA; Walkinshaw E; Tan HK; Lubina-Solomon A; Kumareswaran K; Lane AP; Chadwick T; Marshall SM; Speight J; Flanagan D; Heller SR; Shaw JA; Evans ML
    Diabetes Care; 2013 Dec; 36(12):4063-70. PubMed ID: 24130355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between recent exposure to continuous glucose monitoring-recorded hypoglycaemia and counterregulatory and symptom responses to subsequent controlled hypoglycaemia in people with type 1 diabetes.
    Svensson CH; Fabricius TW; Verhulst CEM; Kristensen PL; Tack CJ; Heller SR; Amiel SA; McCrimmon RJ; Evans M; Holst JJ; de Galan BE; Pedersen-Bjergaard U;
    Diabetes Obes Metab; 2024 Aug; 26(8):3213-3222. PubMed ID: 38774963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoglycaemia frequency and physiological response after double or triple doses of once-weekly insulin icodec vs once-daily insulin glargine U100 in type 2 diabetes: a randomised crossover trial.
    Pieber TR; Arfelt KN; Cailleteau R; Hart M; Kar S; Mursic I; Svehlikova E; Urschitz M; Haahr H
    Diabetologia; 2023 Aug; 66(8):1413-1430. PubMed ID: 37308751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cold-induced dishabituation in rodents exposed to recurrent hypoglycaemia.
    Vickneson K; Blackburn J; Gallagher JR; Evans ML; de Galan BE; Pedersen-Bjergaard U; Thorens B; McNeilly AD; McCrimmon RJ
    Diabetologia; 2021 Jun; 64(6):1436-1441. PubMed ID: 33730186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycaemic thresholds for counterregulatory hormone and symptom responses to hypoglycaemia in people with and without type 1 diabetes: a systematic review.
    Verhulst CEM; Fabricius TW; Teerenstra S; Kristensen PL; Tack CJ; McCrimmon RJ; Heller S; Evans ML; Amiel SA; Pedersen-Bjergaard U; de Galan BE;
    Diabetologia; 2022 Oct; 65(10):1601-1612. PubMed ID: 35867127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Intensity Exercise as a Dishabituating Stimulus Restores Counterregulatory Responses in Recurrently Hypoglycemic Rodents.
    McNeilly AD; Gallagher JR; Huang JT; Ashford MLJ; McCrimmon RJ
    Diabetes; 2017 Jun; 66(6):1696-1702. PubMed ID: 28270522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flexible insulin therapy with a hybrid regimen of insulin degludec and continuous subcutaneous insulin infusion with pump suspension before exercise in physically active adults with type 1 diabetes (FIT Untethered): a single-centre, open-label, proof-of-concept, randomised crossover trial.
    Aronson R; Li A; Brown RE; McGaugh S; Riddell MC
    Lancet Diabetes Endocrinol; 2020 Jun; 8(6):511-523. PubMed ID: 32445738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of short-term use of dapagliflozin on impaired awareness of hypoglycaemia in people with type 1 diabetes.
    van Meijel LA; Tack CJ; de Galan BE
    Diabetes Obes Metab; 2021 Nov; 23(11):2582-2589. PubMed ID: 34338413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin degludec is not associated with a delayed or diminished response to hypoglycaemia compared with insulin glargine in type 1 diabetes: a double-blind randomised crossover study.
    Koehler G; Heller S; Korsatko S; Roepstorff C; Rasmussen S; Haahr H; Pieber TR
    Diabetologia; 2014 Jan; 57(1):40-9. PubMed ID: 24057153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Counterregulatory hormone and symptom responses to hypoglycaemia in people with type 1 diabetes, insulin-treated type 2 diabetes or without diabetes: the Hypo-RESOLVE hypoglycaemic clamp study.
    Fabricius TW; Verhulst CEM; Kristensen PL; Holst JJ; Tack CJ; McCrimmon RJ; Heller SR; Evans ML; de Galan BE; Pedersen-Bjergaard U;
    Acta Diabetol; 2024 May; 61(5):623-633. PubMed ID: 38376580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A real-life comparison of hypoglycaemia symptomatology between insulin-treated type 2 diabetes participants with and without impaired awareness of hypoglycaemia.
    Lee WK; Ko MSM; Ang LC; Zhu L; Bee YM; Goh SY; Teh MM
    Diabet Med; 2023 Nov; 40(11):e15215. PubMed ID: 37640970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.
    van Beers CA; DeVries JH; Kleijer SJ; Smits MM; Geelhoed-Duijvestijn PH; Kramer MH; Diamant M; Snoek FJ; Serné EH
    Lancet Diabetes Endocrinol; 2016 Nov; 4(11):893-902. PubMed ID: 27641781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single-blind, randomised, crossover study to reduce hypoglycaemia risk during postprandial exercise with closed-loop insulin delivery in adults with type 1 diabetes: announced (with or without bolus reduction) vs unannounced exercise strategies.
    Tagougui S; Taleb N; Legault L; Suppère C; Messier V; Boukabous I; Shohoudi A; Ladouceur M; Rabasa-Lhoret R
    Diabetologia; 2020 Nov; 63(11):2282-2291. PubMed ID: 32740723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired hypoglycaemia awareness in type 1 diabetes: lessons from the lab.
    McNeilly AD; McCrimmon RJ
    Diabetologia; 2018 Apr; 61(4):743-750. PubMed ID: 29417183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of preservation of higher brain function during hypoglycaemia in patients with intensively-treated IDDM.
    Maran A; Lomas J; Macdonald IA; Amiel SA
    Diabetologia; 1995 Dec; 38(12):1412-8. PubMed ID: 8786014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with Type 1 diabetes and impaired awareness of hypoglycaemia.
    Reddy M; Jugnee N; El Laboudi A; Spanudakis E; Anantharaja S; Oliver N
    Diabet Med; 2018 Apr; 35(4):483-490. PubMed ID: 29230878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental non-severe hypoglycaemia substantially impairs cognitive function in type 2 diabetes: a randomised crossover trial.
    Nilsson M; Jensen N; Gejl M; Bergmann ML; Storgaard H; Zander M; Miskowiak K; Rungby J
    Diabetologia; 2019 Oct; 62(10):1948-1958. PubMed ID: 31367958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.